DEFR14A: Nuburu Inc. Seeks Stockholder Approval for $35 Million Non-Public Securities Issuance

Nuburu Inc. is seeking stockholder approval to issue up to $35 million in securities, potentially diluting existing shares, to raise capital for working capital and general corporate purposes.

Summary

• Nuburu Inc. has issued a supplement to its definitive proxy statement regarding its 2024 Annual Meeting of Stockholders.
• The supplement clarifies that Proposal No. 5 seeks authorization for the issuance of up to $35 million of securities in non-public offerings.
• The maximum number of shares issuable under this proposal is 106 million, calculated based on a 30% discount to the market price as of November 22, 2024.
• The company intends to use the proceeds for working capital and general corporate purposes.
• Proposal No. 7, concerning the adjournment of the Annual Meeting, has been reclassified as a routine matter by the New York Stock Exchange.
• This means brokers can vote on this proposal even if they don't receive instructions from beneficial owners.

Sentiment

Score: 5

Explanation: The document is neutral in tone, outlining a necessary capital raise with potential dilution. It is a standard corporate action, but the potential dilution and discount are concerning.

Positives

• The company is proactively seeking capital to implement its business strategy and enhance its overall capitalization.
• The company is clarifying the terms of the proposed securities issuance to provide more transparency to stockholders.
• The reclassification of Proposal No. 7 as a routine matter simplifies the voting process for brokers.

Negatives

• The issuance of new shares will dilute existing stockholders' ownership.
• The potential for a 30% discount on the new shares could negatively impact the value of existing shares.
• The company has not yet determined the specific terms of the offering, creating uncertainty for investors.
• The issuance of shares could have an anti-takeover effect, potentially deterring mergers or acquisitions.

Risks

• The company may not be successful in raising the desired capital through these offerings.
• The dilution of existing shares could negatively impact the stock price.
• The concentration of voting power in the hands of a few investors could influence the company's operations.
• The company has not yet determined the terms and conditions of any offerings.

Future Outlook

The company intends to use the net proceeds of any offerings for working capital and general corporate purposes, but has no specific arrangements with investors at this time.

Management Comments

• The Board recommends that the stockholders vote for the approval of the issuance of up to $35 million of securities (or 106 million shares of common stock).
• The company is seeking stockholder approval now, so that we will be able to move quickly to take full advantage of any opportunities that may develop.

Industry Context

This announcement is typical for companies seeking to raise capital for growth and operations, and the need for shareholder approval for large issuances is standard practice under NYSE American rules.

Comparison to Industry Standards

• Many companies in the technology sector, particularly those in growth phases, often seek additional capital through non-public offerings.
• The 30% discount is within the range of discounts offered in similar private placements, but it is on the higher end.
• The need for shareholder approval for issuances exceeding 20% of outstanding shares is a common requirement for companies listed on exchanges like NYSE American.

Stakeholder Impact

• Existing shareholders will experience dilution of their ownership if the proposal is approved.
• The company's employees may benefit from the increased capital for operations and growth.
• Potential new investors may gain a significant stake in the company.

Next Steps

• Stockholders will vote on Proposal No. 5 at the Annual Meeting on December 27, 2024.
• The company will proceed with the non-public offering if stockholder approval is obtained.
• The company will determine the specific terms of the offering within 90 days of approval.

Key Dates

Keywords

securities issuance, non-public offering, capital raise, stock dilution, proxy statement, annual meeting, NYSE American, common stock, broker non-votes